Is TB-500 Legal in North Carolina? How to Access It Legally

HealthRX.com

No North Carolina rule for TB-500 is established

Print or save as PDF

See the public record for TB-500

  • FDA approval / None; no FDA-approved TB-500 product [1]
  • Federal lists / Not on FDA's pharmacy or outsourcing-facility lists [2][3][4]
  • Advisory vote / July 23, 2026 vote in favor of listing; nonbinding [7][5]
  • HHS policy / Draft enforcement discretion; not an approval [5][6]
  • Human data / FDA found no study in which TB-500 was given to a person [1]
  • Sport / WADA prohibits TB-500 at all times [8][9]

What is TB-500 and is it FDA-approved?

TB-500 is a common name for a synthetic 7-amino-acid fragment (residues 17 to 23, N-acetylated) of the 43-amino-acid protein thymosin beta-4; it is not full-length thymosin beta-4. [1] FDA's July 2026 review found no USP or National Formulary monograph, no FDA-approved drug containing it, and no approved product in Canada, Australia, the UK, several European countries or by the European Medicines Agency. [1] It is sold online as research-use-only injectable powder, alone or blended with BPC-157. [1]

What do federal compounding lists say?

Federal rules let state-licensed pharmacies and physicians compound from a bulk substance only if it complies with an applicable USP or National Formulary monograph, is a component of an FDA-approved drug, or appears on FDA's bulk-substance list. [4] TB-500 appears in none of the three categories on FDA's list for state-licensed pharmacies and physicians (updated May 14, 2026) or on FDA's list for outsourcing facilities (updated March 21, 2025); the category 1 policy does not cover it. [2][3][4] FDA staff proposed in July 2026 that neither TB-500 free base nor acetate be added, citing poor characterization, no human data, immunogenicity risk and existing approved wound treatments. [1] The Pharmacy Compounding Advisory Committee voted in favor on July 23, 2026, against staff's recommendation; the vote is advice only and TB-500 is not on the list. [7][5]

What is the HHS draft policy?

HHS's draft enforcement-discretion policy, filed October 28, 2026, names TB-500 among six peptides and covers TB-500 acetate by subcutaneous or intramuscular injection. [5][6] HHS says it does not intend enforcement action against a state-licensed pharmacy, federal facility or licensed physician compounding with it if conditions are met, such as a single active ingredient, a patient-specific prescription and an FDA-registered manufacturer with a certificate of analysis. [5][6] It is a draft, not an approval or a listing; the notice says it is not binding and HHS may revisit it. [5]

Is there a North Carolina-specific rule?

No North Carolina law or board rule specific to TB-500 is established, so state-level access is unconfirmed. Federal status does not by itself settle what North Carolina allows a prescriber or pharmacy to supply.

Questions worth asking

Choose the questions you want to keep

What about safety and sport?

There is no approved dose, and there are no human dosing, pharmacokinetic or pharmacodynamic data. [1] Animal data show subcutaneous or intraperitoneal TB-500 reaches the bloodstream and is hydrolyzed; no intramuscular animal studies were found. [1] FDA's concern for injectable TB-500 is immunogenicity, potentially amplified by aggregation and impurities, and it found no TB-500 immunogenicity or nonclinical toxicity studies. [1] WADA names 'Thymosin-beta4 and its derivatives e.g. TB-500' in S2.3 and prohibits it at all times; it is on the 2026 and 2027 Lists. [8][9]

Check what you know

Think you have it? Try 5 quick questions and see what the article says.

1. According to the article, what is the status of HHS's draft policy?

Question 1 of 5

Score: 0 right, 0 of 5 answered

Is TB-500 on FDA's compounding lists?
No. It appears in none of the three categories on either list. [2][3][4]
Does the HHS draft policy approve TB-500?
No. It is a draft statement of intended enforcement discretion for TB-500 acetate by injection, not an FDA approval or a listing. [5][6]
Is TB-500 the same as thymosin beta-4?
No. TB-500 is a synthetic 7-amino-acid, N-acetylated fragment (residues 17 to 23) of the 43-amino-acid thymosin beta-4. [1]
Can athletes use TB-500?
WADA prohibits thymosin beta-4 and its derivatives including TB-500 at all times, in and out of competition. It is on the 2026 and 2027 Prohibited Lists. [8][9]
Show all 9 referencesHide references
Evidence overview for Is TB-500 Legal in North Carolina? How to Access It Legally